Navigation Links
Par Pharmaceutical Companies Reports Second Quarter 2011 Results
Date:8/3/2011

nd quarter of 2011 compared to $10.7 million in the first quarter.  The decrease was due to lower generic development costs.
  • Selling, general and administrative expenses for the second quarter 2011 decreased to $46.2 million compared to $46.9 million in the first quarter of 2011.  The decrease reflects lower employment costs.

  • Cash and cash equivalents and marketable securitiesThe aggregate balance as of June 30, 2011 was approximately $346 million.

    Product and Pipeline UpdateIn July, Strativa Pharmaceuticals returned the U.S. commercialization rights of Zuplenz® to its development partner, MonoSol Rx, as part of the branded division's restructuring announced in June.

    In July, the Company received a notice letter from a generic pharmaceutical manufacturer, advising that it has filed an Abbreviated New Drug Application with the U.S. FDA containing a Paragraph IV certification referencing Megace® ES.   Megace® ES is protected by Elan Pharma International Limited's U.S. Patents 6,592,903 and 7,101,576.  The Company intends, with Elan, to investigate the Paragraph IV certification and ANDA, and to enforce its patents, which expire in 2020 and 2024, respectively, as appropriate.

    Par Pharmaceutical, along with third-party partners, currently has approximately 31 ANDAs pending with the FDA, 13 of which it believes to be first-to-file opportunities.

    Conference CallAccess to the live webcast can be made via the Company's website at www.parpharm.com.

    Dial-in InformationDomestic:

    866-362-4832International:

    617-597-5364Passcode:

    55151925A replay of the conference call will be available for two weeks approximately one hour after the call.  

    Replay InformationDomestic:

    888-286-8010International:

    617-801-6888Passcode:

    90475213Non-GAAP MeasuresPar Pharma
    '/>"/>

    SOURCE Par Pharmaceutical Companies, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
    2. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
    3. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
    4. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
    5. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
    6. Novo Nordisk and Partnership of Ivy Equities, LCOR and Intercontinental RE Corp. Announce Lease Agreement for N.J. Pharmaceutical Companys New U.S. Headquarters
    7. FDA Grants Orphan Drug Status to Merrimack Pharmaceuticals MM-398, a Nanotherapeutic Encapsulation of Irinotecan, for the Treatment of Pancreatic Cancer
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
    9. BGI and GT Life Sciences, Inc. Report Genome Sequence of CHO-K1 and Provide New Insights into Optimization of Biopharmaceutical Protein Production
    10. Though Essential to Pharmaceutical Sales Success, the Use of Health Outcomes Data Often Overlooked by Sales Leaders
    11. Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
    (Date:3/2/2015)... Calif. , March 2, 2015 Nevro ... company that has developed and commercialized an innovative, evidence-based ... announced that Brad Vale , PhD, DVM, former ... been appointed to its Board of Directors, effective March ... 30 years of experience in developing, commercializing and investing ...
    (Date:3/2/2015)... 2015  BC Technical, the nation,s leading non-OEM ... Systems, a Nuclear Imaging service company providing systems, ... their ongoing vision to provide the best, and ... Technical continues to expand their reach and expertise. ... valuable resources and knowledge in addition to strengthening ...
    Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2
    ... 10 Biopure Corporation,(Nasdaq: BPUR ) today announced ... have been published in the June 2008 issue of,the ... an Alternative,to Blood Transfusion: Efficacy and Safety Evaluation in ... "It is gratifying to have experts cull through the ...
    ... Endpoints for Advair Diskus(R) ... Compared to ... African American,patients with asthma treated with Advair Diskus, a combination ... propionate, had a lower rate of exacerbations when,compared with patients ...
    Cached Medicine Technology:Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 2Results From One-Year Study Suggest Advair(R) Provides Important Benefits for African American Patients With Asthma 3
    (Date:3/2/2015)... Today the Brain Injury Association of America (BIAA) officially kicked ... support the more than 5.3 million Americans who are living ... nation in observing Brain Injury Awareness Month by conducting an ... the 2015 to 2017 campaign is: Not Alone. , ... general public about the incidence of brain injury and the ...
    (Date:3/2/2015)... Market Publishers Ltd is extremely happy ... Global Industry Analysts Inc and recently added to its ... . Through 2018, the global radiation therapy equipment market ... research report suggests a holistic analysis of the situation ... well as covers the top market trends. The publication ...
    (Date:3/2/2015)... 02, 2015 Tyrone Christopher, Co-founder of ... medium for the model agency industry, have launched Softcandy.sexy, ... Mango, Passion Fruit, Pink Grapefruit, Pomegranate, and or Vanilla ... 1pm. , At a cost of alienating a few ... fire by announcing the brands commitment and support of ...
    (Date:3/2/2015)... 02, 2015 After a rigorous evaluation ... service, pricing and long-term strategy, Blood Centers of America ... choice for member centers’ testing needs. , BCA, which ... more than 30 percent of the U.S. blood supply, ... “BCA is committed to drive cost savings to members,” ...
    (Date:3/2/2015)... View, CA (PRWEB) March 02, 2015 ... today that it has officially launched a multivitamin ... Gustafsson, head of product development for BNatrl, said ... through feedback from Olympic and other world-class athletes. ... excited to use this pure whole food multivitamin ...
    Breaking Medicine News(10 mins):Health News:Brain Injury Association of America Launches “Not Alone” Campaign for Brain Injury Awareness Month 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Bnatrl Launches Multivitamin Supplement for Runners 2
    ... ... a permanent solution to the Medicare physician payment system this year, says MedicareSupplementPlans.com ... Los ... year designed to improve the way Medicare pays physicians while still keeping Medicare costs ...
    ... , Senate Finance Committee Urged Not to Include ... WASHINGTON, Aug. 7 America,s local and regional independent ... provision imposing a 20% co-pay on laboratory services under Medicare. ... this provision would shift billions of dollars in costs to senior ...
    ... Duane Reade Holdings, Inc. announced today that its wholly-owned ... had closed their offering of $300.0 million aggregate principal amount ... The Notes bear interest at an annual rate of ... yield to maturity of 12.375%. The Notes were issued ...
    ... serious cardiovascular issues: study , FRIDAY, Aug. 7 (HealthDay ... is a reliable predictor of cardiovascular complications in people ... -- kidney damage caused by diabetes. , The study ... 2007. Those with increased levels of IgM in their ...
    ... , , , ... will learn how to use the latest technology to help keep ... California Partnership to End Domestic Violence (CPEDV) and Verizon. , ... the Verizon Foundation, the philanthropic arm of Verizon, is designed to ...
    ... the Yerkes National Primate Research Center, Emory University, believe ... explored in the development of an effective AIDS vaccine. ... nonhuman primates, they propose an additional new approach to ... in the August issue of Nature Medicine . ...
    Cached Medicine News:Health News:Congress Unlikely to Pass Permanent Medicare Physician Payment Fix in 2009, says MedicareSupplementPlans.com 2Health News:Seniors: Get Your Checkbooks Ready 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 2Health News:Duane Reade Holdings, Inc. Announces Closing of Offering of $300 Million of 11.75% Senior Secured Notes Due 2015 3Health News:Immunoglobulin Can Predict Some Diabetic Complications 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 2Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 3Health News:Verizon and California Partnership to End Domestic Violence Launch Program to Help Victims Protect Themselves by Using Technology 4Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 2Health News:Yerkes researchers propose ambitious new strategies for AIDS vaccine research 3
    Excellent during IOL insertion while pushing the trailing haptic into position. Gently curved shaft and round handle....
    Ideal for nucleus manipulation during phacoemulsification. Also used for manipulating and rotating IOLs within the anterior chamber. Round knurled handle...
    Short, narrow paddle angled 45 degree inserts through the side port stab incision and is ideal for effective manipulation of the lens during anterior chamber phacoemulsification....
    Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique. Round knurled handle. Manufactured in titanium....
    Medicine Products: